FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2022/09/045268 [Registered on: 06/09/2022] Trial Registered Prospectively
Last Modified On: 05/09/2022
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Clinical trial of nagaradi churna on kaphaja pandu w.s.r to iron deficiency anemia  
Scientific Title of Study   Randomized open controlled clinical trial of nagaradi churna on kaphaja pandu w s r to anemia  
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Diksha Chandrakant Sonwane  
Designation  PG scholar  
Affiliation  Yashwant ayurvedic medical College and Research Center kodoli 
Address  Yashwant Ayurvedic Medical College and Research Center Kodoli Tal Panhala Dist Kolhapur
Yashwant Ayurvedic medical College and Research Center Kodoli Tal Panhala Dist Kolhapur
Kolhapur
MAHARASHTRA
416114
India 
Phone  7387424907  
Fax    
Email  dikshasonwane7@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Suryakiran Wagh  
Designation  MD kayachikitsa  
Affiliation  Yashwant ayurvedic medical College and Research Center Kodoli  
Address  kayachikitsa department Yashwant Ayurvedic Medical College and Research Center Kodoli Tal Panhala Dist Kolhapur
kayachikitsa department Yashwant Ayurvedic Medical College and Research Center Kodoli Tal Panhala Dist Kolhapur
Kolhapur
MAHARASHTRA
416114
India 
Phone  9822846910  
Fax    
Email  Suryakiran_wagh@rediffmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Diksha Sonwane  
Designation  PG Scholar  
Affiliation  Yashwant ayurvedic medical College and Research Center Kodoli  
Address  Yashwant Ayurvedic Medical College and Research Center Kodoli Tal Panhala Dist Kolhapur
Yashwant Ayurvedic Medical College and Research Center Kodoli Tal Panhala Dist Kolhapur
Kolhapur
MAHARASHTRA
416114
India 
Phone  7387424907  
Fax    
Email  dikshasonwane7@gmail.com  
 
Source of Monetary or Material Support  
Yashwant Ayurvedic college post graduate training and Research Center, Kodoli  
 
Primary Sponsor  
Name  Dr Diksha Sonwane  
Address  Yashwant Ayurvedic Medical College and Research Center Kodoli Tal Panhala Dist Kolhapur 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
Nil  Nil 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Diksha Chandrakant Sonwane   Diksha Chandrakant Sonwane   Room no 17 kayachikitsa department Yashwant Ayurvedic medical college and research centre kodoli,Panhala
Kolhapur
MAHARASHTRA 
7387424907

dikshasonwane7@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee, Yashwant Ayurvedic college,PGT and RC Kodoli  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:D648||Other specified anemias. Ayurveda Condition: PANDUROGAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator Arm (Non Ayurveda)-Ferrous sulphate Rout oral Dosage 100 mg Frequency once a day Duration 90 days
2Intervention ArmDrugClassical(1) Medicine Name: Nagaradi churna , Reference: Yog ratnakar , Route: Oral, Dosage Form: Churna/ Powder, Dose: 500(mg), Frequency: od, Bhaishajya Kal: Adhobhakta, Duration: 90 Days, anupAna/sahapAna: Yes(details: -gomutra ), Additional Information: -
 
Inclusion Criteria  
Age From  16.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1.Gender-Patients of any gender will be included.
2.Age-16 yrs to 60 yrs
3.Patients those having Lakshanas of kaphaja Pandu.
4.Hb% ranges above 7gm/dL to 10gm/dL.
5.Patient who shows Panduta,Guruta,Tandra, shithilata, Alasya ,Aruchi, shwas will be included for study.
 
 
ExclusionCriteria 
Details  1.Pregnant women, Lactating mothers.
2.Anemia associated with other known history of diseases like Nephrotic Syndrome, Liver Cirrhosis, Ascites, Congestive Cardiac Failure, Acute Coronary Syndromes, Leprosy, Auto- Immune Disorders etc.
3.Patients having known history of Chronic Blood loss conditions such as Malena, Haemetemesis, Haemorrhagic Piles, Menorrhagia, Metrorrhagia, etc.
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Scales of following symptoms
1)Panduta
2)Guruta
3)Tandra
4)Alasya
5)Shwas
6)Aruchi
7)Shithilata 
2 weeks 
 
Secondary Outcome  
Outcome  TimePoints 
Increase hemoglobin   90 days 
 
Target Sample Size   Total Sample Size="110"
Sample Size from India="110" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   12/09/2022 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   None yet 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   As iron deficiency anemia is the most common type of the anemia
worldwide. In conventional medicine various forms of treatment are used. There are some adverse effects of allopathic treatment. As the anemia is very common prevalent disease in the society, so to get better alternative, an ayurvedic herbo-mineral medicine, Nagaradi Churna will be subjected to a clinical trial in the anemic patients.
The present study was carried out to carry the efficiency of an
Ayurveda herbomineral compound “NAGARADI CHURNA”
 
Close